Biomedical Engineering, Trends, Research and Technologies 2011
DOI: 10.5772/13582
|View full text |Cite
|
Sign up to set email alerts
|

Critical Issues in Reprocessing Single-Use Medical Devices for Interventional Cardiology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0
4

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 45 publications
0
7
0
4
Order By: Relevance
“…According to the European Association for the Reprocessing of Medical Devices, this practice can be performed in almost all European countries, and especially without requiring quality standards. [32][33][34] However, high quality standards are required by regulations in Germany, the Netherlands, Denmark, Sweden, Belgium, Slovakia and Finland. Austria, Luxembourg, the Czech Republic and Slovenia are still undergoing evaluations of the procedure, where [30][31][32][33][34] In France, reprocessing is prohibited and in the United Kingdom, the Medicines and Healthcare Products Regulatory Agency (MHRA), which is a union of The Medicines Control Agency, and The Medical Devices Agency issued a statement in 2003 against the practice, claiming that the practice may compromise the safety, performance and effectiveness of the devices, and that the risk to patients outweighs any benefit.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…According to the European Association for the Reprocessing of Medical Devices, this practice can be performed in almost all European countries, and especially without requiring quality standards. [32][33][34] However, high quality standards are required by regulations in Germany, the Netherlands, Denmark, Sweden, Belgium, Slovakia and Finland. Austria, Luxembourg, the Czech Republic and Slovenia are still undergoing evaluations of the procedure, where [30][31][32][33][34] In France, reprocessing is prohibited and in the United Kingdom, the Medicines and Healthcare Products Regulatory Agency (MHRA), which is a union of The Medicines Control Agency, and The Medical Devices Agency issued a statement in 2003 against the practice, claiming that the practice may compromise the safety, performance and effectiveness of the devices, and that the risk to patients outweighs any benefit.…”
Section: Resultsmentioning
confidence: 99%
“…[32][33][34] However, high quality standards are required by regulations in Germany, the Netherlands, Denmark, Sweden, Belgium, Slovakia and Finland. Austria, Luxembourg, the Czech Republic and Slovenia are still undergoing evaluations of the procedure, where [30][31][32][33][34] In France, reprocessing is prohibited and in the United Kingdom, the Medicines and Healthcare Products Regulatory Agency (MHRA), which is a union of The Medicines Control Agency, and The Medical Devices Agency issued a statement in 2003 against the practice, claiming that the practice may compromise the safety, performance and effectiveness of the devices, and that the risk to patients outweighs any benefit. 28 One of the countries with the highest quality control of the catheter reuse process is the United States, which has a disposable medical device reuse rate in about 25% of hospitals.…”
Section: Resultsmentioning
confidence: 99%
“…In Italy it was found that the very high demands placed on in the reprocessing single-use instruments can hardly be met by small- and mid-scale health care institutions [ 42 ]. The health authority in UK warns of reprocessing single-use medical devices due to the occurrence of events with negative consequences for the patient [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…With the development of newly fabrication materials such as plastic polymers the single-use medical devices (SUDs) have been booming since the late 1970s [1]. The original intention of SUDs stemmed from a desire to improve product performance and minimize the potential for disease transmission.…”
Section: Introductionmentioning
confidence: 99%
“…However, the increasing number of interventions and the consequent economic burden on health-care systems had led many countries to consider a reprocessing policy. Although there were controversial results associated with the safety and effectiveness of SUDs reprocessing and reuse [2–5], little evidence so far on its safety and efficacy has been published [6, 7], and the practice remains common in the most countries worldwide [1, 8–12].…”
Section: Introductionmentioning
confidence: 99%